AI Platform
Advanced AI-integrated tooling to accelerate next-generation therapeutic discovery and design.
Overview
Our advanced AI-integrated platform is under active development and is designed to accelerate the discovery and design of next-generation therapeutics. The platform leverages machine learning and predictive analytics for comprehensive genomic analysis, variant calling, and epitope identification.
By combining multi-omics data with structural and immunoinformatics models, the system supports personalized cancer vaccine design and precision monoclonal antibody (mAb) engineering.
Through continuous refinement, our AI platform aims to transform complex biological data into actionable insights — enabling faster, more accurate, and cost-effective therapeutic innovation.
What it enables
- Scalable genomic & transcriptomic analysis pipelines (variant calling, neoantigen discovery, epitope ranking)
- Multi-omics fusion with structural and immunoinformatics models
- Personalized cancer vaccine design and precision mAb engineering
- Actionable insights with improved speed, accuracy, and cost efficiency